Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative Colitis-Reference-Cited by-同舟云学术

Mesalamine Inhibits Epithelial β-Catenin Activation in Chronic Ulcerative Colitis

Published:2010-02 Issue:2 Volume:138 Page:595-605.e3
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Brown Jeffrey B.,Lee Goo,Managlia Elizabeth,Grimm Gery R.,Dirisina Ramanarao,Goretsky Tatiana,Cheresh Paul,Blatner Nichole R.,Khazaie Khashayarsha,Yang Guang–Yu,Li Linheng,Barrett Terrence A.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference59 articles.

1. Increased risk of cancer in ulcerative colitis: a population-based cohort study;Karlen;Am J Gastroenterol,1999

2. Ulcerative colitis and colorectal cancer;Ekbom;N Engl J Med,1990

3. Cancer risk in patients with inflammatory bowel disease: a population-based study;Bernstein;Cancer,2001

4. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies;Velayos;Am J Gastroenterol,2005

5. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis;Rubin;Clin Gastroenterol Hepatol,2006

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in molecular mechanisms of inflammatory bowel disease‑associated colorectal cancer (Review);Oncology Letters;2024-04-09

2. Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer;Molecules;2023-06-29

3. Cancer evolution: Special focus on the immune aspect of cancer;Seminars in Cancer Biology;2022-11

4. Antioxidant Properties, Phytoactive Compounds and Potential Protective Action of Salvia officinalis Flowers Against Combined Gastro-Intestinal Ulcer and Diarrhea Experimentally Induced in Rat;Dose-Response;2022-04

5. Mesalazine initiates an anti-oncogenic β-catenin / MUCDHL negative feed-back loop in colon cancer cells by cell-specific mechanisms;Biomedicine & Pharmacotherapy;2022-02